DK2964623T3 - Substituerede chroman-6-yloxycycloalkaner og deres anvendelse som farmaceutik - Google Patents

Substituerede chroman-6-yloxycycloalkaner og deres anvendelse som farmaceutik Download PDF

Info

Publication number
DK2964623T3
DK2964623T3 DK14710222.2T DK14710222T DK2964623T3 DK 2964623 T3 DK2964623 T3 DK 2964623T3 DK 14710222 T DK14710222 T DK 14710222T DK 2964623 T3 DK2964623 T3 DK 2964623T3
Authority
DK
Denmark
Prior art keywords
yloxycycloalkanes
pharmaceutical
substituted chroman
chroman
substituted
Prior art date
Application number
DK14710222.2T
Other languages
English (en)
Inventor
Werngard Czechtizky
John Weston
Nils Rackelmann
Volker Kraft
Petra Arndt
Klaus Wirth
Heinz Goegelein
Olaf Ritzeler
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DK2964623T3 publication Critical patent/DK2964623T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
DK14710222.2T 2013-03-08 2014-03-07 Substituerede chroman-6-yloxycycloalkaner og deres anvendelse som farmaceutik DK2964623T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13305263 2013-03-08
PCT/EP2014/054417 WO2014135674A1 (en) 2013-03-08 2014-03-07 Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
DK2964623T3 true DK2964623T3 (da) 2017-02-13

Family

ID=47901924

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14710222.2T DK2964623T3 (da) 2013-03-08 2014-03-07 Substituerede chroman-6-yloxycycloalkaner og deres anvendelse som farmaceutik

Country Status (24)

Country Link
US (2) US9440941B2 (da)
EP (1) EP2964623B1 (da)
JP (1) JP6282674B2 (da)
KR (1) KR20150128835A (da)
CN (1) CN105008341B (da)
AR (1) AR095057A1 (da)
AU (1) AU2014224579B2 (da)
BR (1) BR112015020259A2 (da)
CA (1) CA2901220C (da)
CY (1) CY1118806T1 (da)
DK (1) DK2964623T3 (da)
ES (1) ES2614050T3 (da)
HR (1) HRP20170147T1 (da)
HU (1) HUE032932T2 (da)
IL (1) IL240177A (da)
LT (1) LT2964623T (da)
MX (1) MX358669B (da)
PL (1) PL2964623T3 (da)
PT (1) PT2964623T (da)
RU (1) RU2666350C2 (da)
SG (1) SG11201506091QA (da)
SI (1) SI2964623T1 (da)
TW (1) TWI633095B (da)
WO (1) WO2014135674A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9701671B2 (en) * 2015-02-20 2017-07-11 Canon Kabushiki Kaisha Organic compound, electrochromic element containing the same, optical filter, lens unit, imaging device, and window component
CN108939075A (zh) * 2018-07-26 2018-12-07 陕西师范大学 Ncx1基因作为治疗呼吸暂停综合症的药物干预靶点的应用
CN113968883A (zh) * 2020-07-23 2022-01-25 南京工业大学 光学色酮衍生物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5952421B2 (ja) * 1976-07-31 1984-12-19 コニカ株式会社 色素画像褪色防止剤を含有するカラ−写真材料
JPH0967336A (ja) 1995-09-04 1997-03-11 Kanebo Ltd 新規なイソチオウレア誘導体
US6156801A (en) 1997-03-27 2000-12-05 Taisho Pharmaceutical Co., Ltd. 2-phenoxyaniline derivatives
AU2001295951A1 (en) 2000-10-18 2002-04-29 Senju Pharmaceutical Co. Ltd. Novel 4-benzyloxyphenyl derivative and use thereof
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
AU2003244181A1 (en) 2002-06-25 2004-01-06 Yamanouchi Pharmaceutical Co., Ltd. Phenoxypyridine derivative or salt thereof
FI20030030A0 (fi) * 2003-01-09 2003-01-09 Orion Corp Uusia yhdisteitä
TWI346112B (en) * 2004-02-25 2011-08-01 Nissan Chemical Ind Ltd Benzopyran compound
JP5092111B2 (ja) 2007-02-05 2012-12-05 トーアエイヨー株式会社 ブトキシアニリン誘導体
EP2103939A1 (en) 2008-03-20 2009-09-23 sanofi-aventis Fluorescence based assay to detect sodium/calcium exchanger (NCX) "reverse mode" modulating compounds
EP2348859B1 (en) 2008-10-01 2013-12-04 Merck Sharp & Dohme Corp. Prodrugs of oxazolidinone cetp inhibitors
US8912224B2 (en) 2011-09-12 2014-12-16 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
PL2567958T3 (pl) * 2011-09-12 2015-04-30 Sanofi Sa Podstawione 2-(chroman-6-yloksy)-tiazole i ich zastosowanie jako środków leczniczych

Also Published As

Publication number Publication date
US9440941B2 (en) 2016-09-13
LT2964623T (lt) 2017-02-27
CN105008341A (zh) 2015-10-28
RU2666350C2 (ru) 2018-09-07
MX358669B (es) 2018-08-31
IL240177A0 (en) 2015-09-24
EP2964623B1 (en) 2016-11-02
AU2014224579B2 (en) 2018-05-10
KR20150128835A (ko) 2015-11-18
CA2901220A1 (en) 2014-09-12
TWI633095B (zh) 2018-08-21
AU2014224579A1 (en) 2015-08-20
JP6282674B2 (ja) 2018-02-21
WO2014135674A1 (en) 2014-09-12
US20170166548A1 (en) 2017-06-15
CA2901220C (en) 2021-05-18
IL240177A (en) 2016-08-31
PL2964623T3 (pl) 2017-04-28
BR112015020259A2 (pt) 2017-07-18
JP2016511266A (ja) 2016-04-14
SG11201506091QA (en) 2015-09-29
CY1118806T1 (el) 2018-01-10
RU2015142274A (ru) 2017-04-20
AR095057A1 (es) 2015-09-16
SI2964623T1 (sl) 2017-03-31
US20160016928A1 (en) 2016-01-21
ES2614050T3 (es) 2017-05-29
TW201522322A (zh) 2015-06-16
HUE032932T2 (en) 2017-11-28
EP2964623A1 (en) 2016-01-13
CN105008341B (zh) 2017-10-24
HRP20170147T1 (hr) 2017-03-24
MX2015010961A (es) 2015-12-17
PT2964623T (pt) 2017-02-13

Similar Documents

Publication Publication Date Title
NO2021012I1 (no) avapritinib and pharmaceutically acceptable salts thereof
DK3608325T3 (da) Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse
DK3277681T3 (da) Imidazolonylquinoliner og deres anvendelse som atm-kinaseinhibitorer
DK3043784T3 (da) Arylethere og anvendelser deraf
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK3149001T3 (da) Hidtil ukendte pyrazolopyrimidinderivater og deres anvendelse som MALT1-hæmmere
DK2968443T3 (da) Hepcidinanaloger og anvendelser deraf
DK3121164T3 (da) Sulfamoylpyrrolamidderivater og anvendelse deraf som medikamenter til behandling af hepatitis b
DK3381917T3 (da) Imidazopyridinforbindelser og anvendelser deraf
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK3030549T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK3347353T3 (da) Pyrazolyl-substituerede heteroaryler og deres anvendelse som lægemidler
DK3029038T3 (da) Tetrazolinonforbindelse og anvendelse deraf
DK2917181T3 (da) Heteroarylderivater og anvendelser deraf
DK3137168T3 (da) Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse
DK2958926T3 (da) Epidithiodioxopiperazinforbindelse eller derivater deraf og anvendelse deraf
DK2861573T3 (da) Oxathiazin-derivater som antibakterielle og anticancer-stoffer
DK2809669T3 (da) Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika
DK3064491T3 (da) Sulfonamidderivat og medicinsk anvendelse deraf
BR302013005964S1 (pt) Configuração aplicada em cadeira
DK3066089T3 (da) Substituerede n-acetyl-l-cysteinderivater og relaterede forbindelser
DK3057963T3 (da) Piperazinderivater og anvendelse deraf som lægemidler